ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NVCN Neovasc Inc

30.03
0.00 (0.0%)
Last Updated: 19:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 27.70
Ask Price 30.00
News -
Day High

Low
8.00

52 Week Range

High
30.07

Day Low
Company Name Stock Ticker Symbol Market Type
Neovasc Inc NVCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 30.03 19:00:00
Open Price Low Price High Price Close Price Prev Close
30.03
Trades Volume Avg Volume 52 Week Range
0 0 - 8.00 - 30.07
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 30.03 USD

Neovasc Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 82.70M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Neovasc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVCN Message Board. Create One! See More Posts on NVCN Message Board See More Message Board Posts

Historical NVCN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year8.7030.078.0025.6748,32021.33245.17%
3 Years0.8830.070.291.591,037,30529.153,312.5%
5 Years0.8230.070.291.44952,58929.213,562.2%

Neovasc Description

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com